Galderma Group AG
GALD
Clasificación en acciones
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Precio por acción
$224.81
Capitalización bursátil
$52.42B
Cambio (1 día)
6.31%
Cambio (1 año)
31.28%
País
CH
Comercio Galderma Group AG (GALD)
Categoría
Healthcare
Ratio P/B de Galderma Group AG (GALD)
Ratio P/B al October 2026 TTM: 6.35
Según los informes financieros más recientes y el precio de las acciones de Galderma Group AG, el ratio P/B actual (TTM) es 6.35. Al final de 2024, el ratio P/B era 3.07.
Historial del ratio P/B de Galderma Group AG desde 2021 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 6.35 | 6.85% |
| 2025 | 5.94 | 93.64% |
| 2024 | 3.07 | 10.06% |
| 2023 | 2.79 | -8.45% |
| 2022 | 3.05 | 0.24% |
| 2021 | 3.04 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 1.9834 | -68.75% |
DE
|
|
| 2.1139 | -66.69% |
DE
|
|
| 1.3124 | -79.32% |
JP
|
|
| 5.0287 | -20.77% |
IN
|
|
| 4.7098 | -25.79% |
CN
|
